Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells.

Elliott DM, Singh N, Nagarkatti M, Nagarkatti PS.

Front Immunol. 2018 Aug 3;9:1782. doi: 10.3389/fimmu.2018.01782. eCollection 2018.

2.

Genistein induces macrophage polarization and systemic cytokine to ameliorate experimental colitis.

Abron JD, Singh NP, Price RL, Nagarkatti M, Nagarkatti PS, Singh UP.

PLoS One. 2018 Jul 19;13(7):e0199631. doi: 10.1371/journal.pone.0199631. eCollection 2018.

3.

Evaluation of Cell Proliferation and Apoptosis in Immunotoxicity Testing.

Nagarkatti M, Rieder SA, Nagarkatti PS.

Methods Mol Biol. 2018;1803:209-230. doi: 10.1007/978-1-4939-8549-4_14.

PMID:
29882142
4.

miR-466a Targeting of TGF-β2 Contributes to FoxP3+ Regulatory T Cell Differentiation in a Murine Model of Allogeneic Transplantation.

Becker W, Nagarkatti M, Nagarkatti PS.

Front Immunol. 2018 Apr 9;9:688. doi: 10.3389/fimmu.2018.00688. eCollection 2018.

5.

An endogenous aryl hydrocarbon receptor ligand, ITE, induces regulatory T cells and ameliorates experimental colitis.

Abron JD, Singh NP, Mishra MK, Price RL, Nagarkatti M, Nagarkatti PS, Singh UP.

Am J Physiol Gastrointest Liver Physiol. 2018 Aug 1;315(2):G220-G230. doi: 10.1152/ajpgi.00413.2017. Epub 2018 Apr 19.

PMID:
29672155
6.
7.

Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity.

Sagar D, Singh NP, Ginwala R, Huang X, Philip R, Nagarkatti M, Nagarkatti P, Neumann K, Ruland J, Andrews AM, Ramirez SH, Khan ZK, Jain P.

Sci Rep. 2017 Jun 2;7(1):2707. doi: 10.1038/s41598-017-03027-x.

8.

CD44 deletion leading to attenuation of experimental autoimmune encephalomyelitis results from alterations in gut microbiome in mice.

Chitrala KN, Guan H, Singh NP, Busbee B, Gandy A, Mehrpouya-Bahrami P, Ganewatta MS, Tang C, Chatterjee S, Nagarkatti P, Nagarkatti M.

Eur J Immunol. 2017 Jul;47(7):1188-1199. doi: 10.1002/eji.201646792. Epub 2017 Jun 6.

9.

MicroRNAs associated with the pathogenesis of multiple sclerosis.

Huang Q, Xiao B, Ma X, Qu M, Li Y, Nagarkatti P, Nagarkatti M, Zhou J.

J Neuroimmunol. 2016 Jun 15;295-296:148-61. doi: 10.1016/j.jneuroim.2016.04.014. Epub 2016 Apr 27. Review.

PMID:
27235360
10.

Apigenin, a Natural Flavonoid, Attenuates EAE Severity Through the Modulation of Dendritic Cell and Other Immune Cell Functions.

Ginwala R, McTish E, Raman C, Singh N, Nagarkatti M, Nagarkatti P, Sagar D, Jain P, Khan ZK.

J Neuroimmune Pharmacol. 2016 Mar;11(1):36-47. doi: 10.1007/s11481-015-9617-x. Epub 2015 Jun 4.

11.

Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease.

Sido JM, Nagarkatti PS, Nagarkatti M.

Int Rev Immunol. 2015;34(5):403-14. doi: 10.3109/08830185.2014.921165. Epub 2014 Jun 9. Review.

12.

3,3'-diindolylmethane ameliorates experimental autoimmune encephalomyelitis by promoting cell cycle arrest and apoptosis in activated T cells through microRNA signaling pathways.

Rouse M, Rao R, Nagarkatti M, Nagarkatti PS.

J Pharmacol Exp Ther. 2014 Aug;350(2):341-52. doi: 10.1124/jpet.114.214742. Epub 2014 Jun 4.

13.

The severity of experimental autoimmune cystitis can be ameliorated by anti-CXCL10 Ab treatment.

Singh UP, Singh NP, Guan H, Hegde VL, Price RL, Taub DD, Mishra MK, Nagarkatti M, Nagarkatti PS.

PLoS One. 2013 Nov 21;8(11):e79751. doi: 10.1371/journal.pone.0079751. eCollection 2013.

14.

The emerging role of leptin antagonist as potential therapeutic option for inflammatory bowel disease.

Singh UP, Singh NP, Guan H, Busbee B, Price RL, Taub DD, Mishra MK, Fayad R, Nagarkatti M, Nagarkatti PS.

Int Rev Immunol. 2014 Jan;33(1):23-33. doi: 10.3109/08830185.2013.809071. Epub 2013 Jul 10. Review.

15.

Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders.

Busbee PB, Rouse M, Nagarkatti M, Nagarkatti PS.

Nutr Rev. 2013 Jun;71(6):353-69. doi: 10.1111/nure.12024. Epub 2013 Apr 1. Review.

16.

Indoles mitigate the development of experimental autoimmune encephalomyelitis by induction of reciprocal differentiation of regulatory T cells and Th17 cells.

Rouse M, Singh NP, Nagarkatti PS, Nagarkatti M.

Br J Pharmacol. 2013 Jul;169(6):1305-21. doi: 10.1111/bph.12205.

17.

MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis.

Guan H, Fan D, Mrelashvili D, Hao H, Singh NP, Singh UP, Nagarkatti PS, Nagarkatti M.

Eur J Immunol. 2013 Jan;43(1):104-14. doi: 10.1002/eji.201242702. Epub 2012 Nov 29.

18.

The role of IL-2 in the activation and expansion of regulatory T-cells and the development of experimental autoimmune encephalomyelitis.

Rouse M, Nagarkatti M, Nagarkatti PS.

Immunobiology. 2013 Apr;218(4):674-82. doi: 10.1016/j.imbio.2012.08.269. Epub 2012 Aug 9.

19.

Prenatal exposure of mice to diethylstilbestrol disrupts T-cell differentiation by regulating Fas/Fas ligand expression through estrogen receptor element and nuclear factor-κB motifs.

Singh NP, Singh UP, Nagarkatti PS, Nagarkatti M.

J Pharmacol Exp Ther. 2012 Nov;343(2):351-61. doi: 10.1124/jpet.112.196121. Epub 2012 Aug 10.

Supplemental Content

Loading ...
Support Center